EUVIMED · CrossrefZeitschrift
Supportive Cancer Therapy
ISSN 1543-2912 · Elsevier BV
Neueste Artikel
Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation?
Prevention and Treatment of Salivary Gland Hypofunction Related to Head and Neck Radiation Therapy and Chemotherapy
Supportive Care in Colon Cancer
Selected Clinical Trials in Supportive Cancer Therapy
Utility of Cancer Web Sites for a Public Hospital Empoli (Florence), Italy Oncology Population in Tuscany, Italy
Selected Clinical Trials in Supportive Cancer Therapy
Highlights from: The 48th Annual Meeting of the American Society of Hematology; Orlando, FL
Selected Clinical Trials in Supportive Cancer Therapy
Highlights from: The 24th Annual Miami Breast Cancer Conference; Miami, FL; March 14–17, 2007
Selected Clinical Trials in Supportive Cancer Therapy
Highlights from: The 46th Annual Meeting of the American Society of Hematology; San Diego, CA, December 2004
Palifermin Is Efficacious in Reducing Oral Mucositis Induced by Intensive Cancer Therapy
Role of Prophylactic Quinolones in Reducing Febrile Neutropenia in Patients Undergoing Myelosuppressive Chemotherapy
Moving Beyond Febrile Neutropenia
A Brief Update on the Biomechanisms Underlying Cement Injection and Leakage in Vertebroplasty
Highlights from: Third Annual Future of Supportive Therapy in Oncology, San Francisco, CA, February 2005; 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 2004; 46th Annual Meeting of the American Society of Hematology, San Diego, CA December 2004
Pegfilgrastim: Recent Advances in the Prophylaxis of Chemotherapy-Induced Neutropenia
Novel Thrombopoetin Mimetic Agents with Potential to Ameliorate Chemotherapy-Induced Thrombocytopenia
Impact of Erythropoietic Agents on Survival of Anemic Patients with Cancer
Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies
The Role of Plerixafor (AMD3100) in Mobilizing Hematopoietic Progenitor Cells in Patients with Hematologic Malignancies
Increasing the Number of Patients in Palliative Research: Ethical Considerations
Erythropoietic Therapy: Who, How, and When?
Words That Make a Difference: Enhancing the “How” in “How We Say It”
Selected Clinical Trials in Supportive Cancer Therapy
Highlights from: The 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois
Early Initiation of Epoetin Alfa Prevents Development of Chemotherapy-Associated Anemia and Preserves Quality of Life
The Use of Recombinant Human Keratinocyte Growth Factor (Palifermin) to Ameliorate Treatment-Induced Mucositis
Hematopoietic Cytokines: When Treating the Symptoms Does Not Treat the Disease
Instructions to Authors
EUVIMED